<?xml version="1.0" encoding="UTF-8"?>
<p>In our continuing search for biologically active metabolites of traditional medicinal plants from the Venda area in South Africa, we investigated 
 <italic>Rauvolfia caffra</italic>, which is widely used in medicine in Sub-Sahara African communities to treat a range of ailments such as toothaches, hysteria, epilepsy, eye diseases, skin wounds, urticaria, severe abdominal pains, diarrhoea, headaches, constipation, irregular periods, swollen legs, palpitation of the heart, insomnia, insecurity, restlessness, anxiety and earache [
 <xref rid="B15-molecules-25-03781" ref-type="bibr">15</xref>,
 <xref rid="B16-molecules-25-03781" ref-type="bibr">16</xref>,
 <xref rid="B17-molecules-25-03781" ref-type="bibr">17</xref>,
 <xref rid="B18-molecules-25-03781" ref-type="bibr">18</xref>,
 <xref rid="B19-molecules-25-03781" ref-type="bibr">19</xref>,
 <xref rid="B20-molecules-25-03781" ref-type="bibr">20</xref>]. Previously, we isolated three indole alkaloids (raucaffricine, 
 <italic>N</italic>-methylsarpagine and spegatrine) and one terpenoid (lupeol) from the stem bark of 
 <italic>Rauvolfia caffra</italic> and found that the major constituents do not contribute to the antiplasmodial activity of 
 <italic>R. caffra</italic> [
 <xref rid="B21-molecules-25-03781" ref-type="bibr">21</xref>].
</p>
